Logo image of ALAUD.PA

AUDACIA SA (ALAUD.PA) Stock Fundamental Analysis

EPA:ALAUD - Euronext Paris - Matif - FR00140059B5 - Common Stock - Currency: EUR

3.22  -0.16 (-4.73%)

Fundamental Rating

4

Overall ALAUD gets a fundamental rating of 4 out of 10. We evaluated ALAUD against 106 industry peers in the Capital Markets industry. While ALAUD seems to be doing ok healthwise, there are quite some concerns on its profitability. ALAUD has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALAUD had negative earnings in the past year.
ALAUD had a negative operating cash flow in the past year.
ALAUD had positive earnings in each of the past 5 years.
In multiple years ALAUD reported negative operating cash flow during the last 5 years.
ALAUD.PA Yearly Net Income VS EBIT VS OCF VS FCFALAUD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M

1.2 Ratios

ALAUD has a Return On Assets (-0.61%) which is in line with its industry peers.
ALAUD has a Return On Equity of -1.19%. This is comparable to the rest of the industry: ALAUD outperforms 46.23% of its industry peers.
Industry RankSector Rank
ROA -0.61%
ROE -1.19%
ROIC N/A
ROA(3y)4.85%
ROA(5y)4.68%
ROE(3y)10.84%
ROE(5y)14.31%
ROIC(3y)N/A
ROIC(5y)N/A
ALAUD.PA Yearly ROA, ROE, ROICALAUD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 5 10 15 20 25

1.3 Margins

ALAUD's Profit Margin has declined in the last couple of years.
ALAUD's Operating Margin has declined in the last couple of years.
The Profit Margin and Operating Margin and Gross Margin are not available for ALAUD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3Y-28.25%
OM growth 5Y-24.47%
PM growth 3Y-37.57%
PM growth 5Y-4.59%
GM growth 3YN/A
GM growth 5YN/A
ALAUD.PA Yearly Profit, Operating, Gross MarginsALAUD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 10 20 30 40

More info and screens

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, ALAUD has about the same amount of shares outstanding.
Compared to 5 years ago, ALAUD has about the same amount of shares outstanding.
The debt/assets ratio for ALAUD has been reduced compared to a year ago.
ALAUD.PA Yearly Shares OutstandingALAUD.PA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
ALAUD.PA Yearly Total Debt VS Total AssetsALAUD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of 1.73, we must say that ALAUD is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ALAUD (1.73) is better than 64.15% of its industry peers.
ALAUD has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
ALAUD has a better Debt to Equity ratio (0.06) than 83.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 1.73
ROIC/WACCN/A
WACCN/A
ALAUD.PA Yearly LT Debt VS Equity VS FCFALAUD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 5M 10M

2.3 Liquidity

ALAUD has a Current Ratio of 1.31. This is a normal value and indicates that ALAUD is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.31, ALAUD is in the better half of the industry, outperforming 67.92% of the companies in the same industry.
ALAUD has a Quick Ratio of 1.31. This is a normal value and indicates that ALAUD is financially healthy and should not expect problems in meeting its short term obligations.
ALAUD's Quick ratio of 1.31 is fine compared to the rest of the industry. ALAUD outperforms 69.81% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
ALAUD.PA Yearly Current Assets VS Current LiabilitesALAUD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for ALAUD have decreased strongly by -155.96% in the last year.
The earnings per share for ALAUD have been decreasing by -16.15% on average. This is quite bad
ALAUD shows a strong growth in Revenue. In the last year, the Revenue has grown by 33.88%.
Measured over the past years, ALAUD shows a decrease in Revenue. The Revenue has been decreasing by -8.15% on average per year.
EPS 1Y (TTM)-155.96%
EPS 3Y-41.69%
EPS 5Y-16.15%
EPS Q2Q%-89.55%
Revenue 1Y (TTM)33.88%
Revenue growth 3Y0.11%
Revenue growth 5Y-8.15%
Sales Q2Q%27.35%

3.2 Future

The Earnings Per Share is expected to grow by 78.69% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 34.31% on average over the next years. This is a very strong growth
EPS Next Y35.29%
EPS Next 2Y51.46%
EPS Next 3Y78.69%
EPS Next 5YN/A
Revenue Next Year34.02%
Revenue Next 2Y31.6%
Revenue Next 3Y34.31%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALAUD.PA Yearly Revenue VS EstimatesALAUD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M
ALAUD.PA Yearly EPS VS EstimatesALAUD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALAUD. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 8.02 indicates a reasonable valuation of ALAUD.
Based on the Price/Forward Earnings ratio, ALAUD is valued cheaper than 90.57% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ALAUD to the average of the S&P500 Index (20.42), we can say ALAUD is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 8.02
ALAUD.PA Price Earnings VS Forward Price EarningsALAUD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALAUD.PA Per share dataALAUD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

ALAUD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALAUD's earnings are expected to grow with 78.69% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.46%
EPS Next 3Y78.69%

More info and screens

0

5. Dividend

5.1 Amount

ALAUD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AUDACIA SA

EPA:ALAUD (5/8/2025, 7:00:00 PM)

3.22

-0.16 (-4.73%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.6%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.04M
Analysts84.44
Price Target9.79 (204.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.78%
Revenue NY rev (3m)0.78%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.02
P/S 1.34
P/FCF N/A
P/OCF N/A
P/B 1.25
P/tB 1.55
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)0.4
Fwd EY12.48%
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS2.4
BVpS2.58
TBVpS2.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.61%
ROE -1.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)4.85%
ROA(5y)4.68%
ROE(3y)10.84%
ROE(5y)14.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)6.13%
ROCE(5y)9.29%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-28.25%
OM growth 5Y-24.47%
PM growth 3Y-37.57%
PM growth 5Y-4.59%
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 7.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 1.73
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)11.38%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-155.96%
EPS 3Y-41.69%
EPS 5Y-16.15%
EPS Q2Q%-89.55%
EPS Next Y35.29%
EPS Next 2Y51.46%
EPS Next 3Y78.69%
EPS Next 5YN/A
Revenue 1Y (TTM)33.88%
Revenue growth 3Y0.11%
Revenue growth 5Y-8.15%
Sales Q2Q%27.35%
Revenue Next Year34.02%
Revenue Next 2Y31.6%
Revenue Next 3Y34.31%
Revenue Next 5YN/A
EBIT growth 1Y-166.69%
EBIT growth 3Y-28.17%
EBIT growth 5Y-30.62%
EBIT Next Year220%
EBIT Next 3Y162.07%
EBIT Next 5YN/A
FCF growth 1Y86.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y93.53%
OCF growth 3Y-23.09%
OCF growth 5YN/A